Furiex Pharmaceuticals
  • Home
  • News
  • About Us
    • Our History
    • Mission, Vision, Values
    • Board of Directors
    • Team Members
  • Why Partner
    • Design Development Programs
    • Risk Sharing
  • Pipeline
    • Priligy®
    • Alogliptin Nesina®
    • Alogliptin/Actos® Combination
    • Alogliptin/Metformin Combination
    • SYR-472
      Trelagliptin
    • Novel Fluoroquinolone
      JNJ-Q2
    • MuDelta
  • Investors
    • News
    • Presentation and Events
    • Corporate Governance
    • Principal Officers
    • SEC Filings
    • Stock Information
    • Insider Ownership
    • E-mail Alerts
    • FAQ
    • Annual Report and Proxy
  • Contact
Sitemap

Sitemap

  • Sitemap

    • 404
    • About Us
      • Our History
      • Mission, Vision, Values
      • Board of Directors
      • Team Members
        • Preclinical and Clinical Operations
          • June Almenoff, M.D., Ph.D., FACP
          • Paul Covington, M.D.
          • Gail McIntyre, Ph.D., CH (ASCP), DABT
          • Michelle Usher, B.S.
          • Lisa Liverman, R.Ph.
          • J. Michael Davenport, Ph.D.
          • Scott Dove, Ph.D.
          • Tim Costello, Ph.D.
          • Rocio Lopez, Ph.D.
          • David Prohaska, B.S.
        • Strategic Development, Finance and Legal
          • Sailash Patel
          • Nadine Chien, Ph.D., Esq.
          • Marshall Woodworth
    • Contact
    • Disclaimer
    • Home
    • Investors
      • News
      • Presentation and Events
      • Corporate Governance
      • Principal Officers
      • SEC Filings
      • Stock Information
      • Insider Ownership
      • E-mail Alerts
      • FAQ
      • Annual Report and Proxy
    • News
    • Pipeline
      • Priligy®
      • Alogliptin Nesina®
      • Alogliptin/Actos® Combination
      • Alogliptin/Metformin Combination
      • SYR-472
        Trelagliptin
      • Novel Fluoroquinolone
        JNJ-Q2
      • MuDelta
    • Privacy Policy
    • Sitemap
    • Why Partner
      • Design Development Programs
      • Risk Sharing
    • Publications
  • PRINT / E-MAIL

    Contact

    EXPERT. FOCUSED. FAST.

    • © 2012 Furiex Pharmaceuticals, Inc. All rights reserved.  
    • About Us
    • Why Partner
    • Pipeline
    • Investors
    • Sitemap
    • Privacy Policy
    • Contact